Go Pro
→ Trump's New Dollar (From Porter & Company) (Ad)tc pixel Free BDMD Stock Alerts

Baird Medical Investment (BDMD) Competitors

Baird Medical Investment logo
$1.09 +0.01 (+0.93%)
Closing price 07/21/2026 04:00 PM Eastern
Extended Trading
$1.07 -0.02 (-1.83%)
As of 07/21/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

BDMD vs. PDEX, INGN, STEX, GUTS, and RCEL

Should you buy Baird Medical Investment stock or one of its competitors? MarketBeat compares Baird Medical Investment with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Baird Medical Investment include Pro-Dex (PDEX), Inogen (INGN), Biosig Technologies (STEX), Fractyl Health (GUTS), and Avita Medical (RCEL). These companies are all part of the "medical equipment" industry.

How does Baird Medical Investment compare to Pro-Dex?

Baird Medical Investment (NASDAQ:BDMD) and Pro-Dex (NASDAQ:PDEX) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, risk, valuation, dividends, earnings, profitability, media sentiment and institutional ownership.

In the previous week, Pro-Dex had 1 more articles in the media than Baird Medical Investment. MarketBeat recorded 1 mentions for Pro-Dex and 0 mentions for Baird Medical Investment. Pro-Dex's average media sentiment score of 0.90 beat Baird Medical Investment's score of 0.00 indicating that Pro-Dex is being referred to more favorably in the news media.

Company Overall Sentiment
Baird Medical Investment Neutral
Pro-Dex Positive

19.8% of Baird Medical Investment shares are held by institutional investors. Comparatively, 15.3% of Pro-Dex shares are held by institutional investors. 78.9% of Baird Medical Investment shares are held by company insiders. Comparatively, 45.9% of Pro-Dex shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Pro-Dex has higher revenue and earnings than Baird Medical Investment.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Baird Medical Investment$22.54M1.98N/AN/AN/A
Pro-Dex$66.59M2.68$8.98M$3.6215.47

Pro-Dex has a consensus target price of $70.00, indicating a potential upside of 24.98%. Given Pro-Dex's stronger consensus rating and higher possible upside, analysts clearly believe Pro-Dex is more favorable than Baird Medical Investment.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Baird Medical Investment
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Pro-Dex
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33

Baird Medical Investment has a beta of -1.17, indicating that its share price is 217% less volatile than the broader market. Comparatively, Pro-Dex has a beta of 0.01, indicating that its share price is 99% less volatile than the broader market.

Pro-Dex has a net margin of 16.08% compared to Baird Medical Investment's net margin of 0.00%. Pro-Dex's return on equity of 22.78% beat Baird Medical Investment's return on equity.

Company Net Margins Return on Equity Return on Assets
Baird Medical InvestmentN/A N/A N/A
Pro-Dex 16.08%22.78%14.30%

Summary

Pro-Dex beats Baird Medical Investment on 11 of the 13 factors compared between the two stocks.

How does Baird Medical Investment compare to Inogen?

Inogen (NASDAQ:INGN) and Baird Medical Investment (NASDAQ:BDMD) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, media sentiment, profitability, dividends, analyst recommendations, institutional ownership, earnings and risk.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inogen
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
2.50
Baird Medical Investment
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Inogen has a beta of 1.58, suggesting that its stock price is 58% more volatile than the broader market. Comparatively, Baird Medical Investment has a beta of -1.17, suggesting that its stock price is 217% less volatile than the broader market.

89.9% of Inogen shares are owned by institutional investors. Comparatively, 19.8% of Baird Medical Investment shares are owned by institutional investors. 2.5% of Inogen shares are owned by company insiders. Comparatively, 78.9% of Baird Medical Investment shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Baird Medical Investment has a net margin of 0.00% compared to Inogen's net margin of -7.08%. Baird Medical Investment's return on equity of 0.00% beat Inogen's return on equity.

Company Net Margins Return on Equity Return on Assets
Inogen-7.08% -12.90% -8.27%
Baird Medical Investment N/A N/A N/A

In the previous week, Inogen had 3 more articles in the media than Baird Medical Investment. MarketBeat recorded 3 mentions for Inogen and 0 mentions for Baird Medical Investment. Inogen's average media sentiment score of 0.20 beat Baird Medical Investment's score of 0.00 indicating that Inogen is being referred to more favorably in the media.

Company Overall Sentiment
Inogen Neutral
Baird Medical Investment Neutral

Baird Medical Investment has lower revenue, but higher earnings than Inogen.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inogen$348.67M0.50-$22.75M-$0.91N/A
Baird Medical Investment$22.54M1.98N/AN/AN/A

Summary

Inogen beats Baird Medical Investment on 7 of the 12 factors compared between the two stocks.

How does Baird Medical Investment compare to Biosig Technologies?

Biosig Technologies (NASDAQ:STEX) and Baird Medical Investment (NASDAQ:BDMD) are both small-cap medical equipment companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, dividends, valuation, earnings, institutional ownership, risk, analyst recommendations and profitability.

Biosig Technologies has a beta of 1.94, meaning that its share price is 94% more volatile than the broader market. Comparatively, Baird Medical Investment has a beta of -1.17, meaning that its share price is 217% less volatile than the broader market.

Baird Medical Investment has higher revenue and earnings than Biosig Technologies.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Biosig Technologies$40K3,677.36-$462.77M-$9.71N/A
Baird Medical Investment$22.54M1.98N/AN/AN/A

7.2% of Biosig Technologies shares are held by institutional investors. Comparatively, 19.8% of Baird Medical Investment shares are held by institutional investors. 52.7% of Biosig Technologies shares are held by insiders. Comparatively, 78.9% of Baird Medical Investment shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Biosig Technologies currently has a consensus target price of $8.00, suggesting a potential upside of 888.75%. Given Biosig Technologies' stronger consensus rating and higher probable upside, analysts plainly believe Biosig Technologies is more favorable than Baird Medical Investment.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Biosig Technologies
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Baird Medical Investment
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Baird Medical Investment's return on equity of 0.00% beat Biosig Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Biosig TechnologiesN/A -717.92% -336.75%
Baird Medical Investment N/A N/A N/A

In the previous week, Biosig Technologies had 6 more articles in the media than Baird Medical Investment. MarketBeat recorded 6 mentions for Biosig Technologies and 0 mentions for Baird Medical Investment. Biosig Technologies' average media sentiment score of 0.48 beat Baird Medical Investment's score of 0.00 indicating that Biosig Technologies is being referred to more favorably in the media.

Company Overall Sentiment
Biosig Technologies Neutral
Baird Medical Investment Neutral

Summary

Biosig Technologies beats Baird Medical Investment on 7 of the 12 factors compared between the two stocks.

How does Baird Medical Investment compare to Fractyl Health?

Fractyl Health (NASDAQ:GUTS) and Baird Medical Investment (NASDAQ:BDMD) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, valuation, media sentiment, analyst recommendations, dividends and profitability.

In the previous week, Fractyl Health had 5 more articles in the media than Baird Medical Investment. MarketBeat recorded 5 mentions for Fractyl Health and 0 mentions for Baird Medical Investment. Fractyl Health's average media sentiment score of 0.48 beat Baird Medical Investment's score of 0.00 indicating that Fractyl Health is being referred to more favorably in the media.

Company Overall Sentiment
Fractyl Health Neutral
Baird Medical Investment Neutral

Baird Medical Investment's return on equity of 0.00% beat Fractyl Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Fractyl HealthN/A -4,053.15% -96.41%
Baird Medical Investment N/A N/A N/A

Baird Medical Investment has higher revenue and earnings than Fractyl Health.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fractyl Health$90K1,357.34-$140.95M-$1.29N/A
Baird Medical Investment$22.54M1.98N/AN/AN/A

Fractyl Health has a beta of 2.29, meaning that its stock price is 129% more volatile than the broader market. Comparatively, Baird Medical Investment has a beta of -1.17, meaning that its stock price is 217% less volatile than the broader market.

Fractyl Health presently has a consensus target price of $5.12, suggesting a potential upside of 564.94%. Given Fractyl Health's stronger consensus rating and higher possible upside, analysts clearly believe Fractyl Health is more favorable than Baird Medical Investment.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Fractyl Health
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.50
Baird Medical Investment
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

19.8% of Baird Medical Investment shares are held by institutional investors. 8.5% of Fractyl Health shares are held by company insiders. Comparatively, 78.9% of Baird Medical Investment shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Fractyl Health beats Baird Medical Investment on 7 of the 12 factors compared between the two stocks.

How does Baird Medical Investment compare to Avita Medical?

Baird Medical Investment (NASDAQ:BDMD) and Avita Medical (NASDAQ:RCEL) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, media sentiment, profitability, risk, earnings, analyst recommendations, dividends and valuation.

Baird Medical Investment has a beta of -1.17, meaning that its stock price is 217% less volatile than the broader market. Comparatively, Avita Medical has a beta of 1.86, meaning that its stock price is 86% more volatile than the broader market.

Avita Medical has a consensus target price of $7.25, indicating a potential upside of 42.44%. Given Avita Medical's stronger consensus rating and higher probable upside, analysts clearly believe Avita Medical is more favorable than Baird Medical Investment.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Baird Medical Investment
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Avita Medical
1 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.43

19.8% of Baird Medical Investment shares are owned by institutional investors. Comparatively, 27.7% of Avita Medical shares are owned by institutional investors. 78.9% of Baird Medical Investment shares are owned by company insiders. Comparatively, 2.2% of Avita Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Avita Medical's average media sentiment score of 0.57 beat Baird Medical Investment's score of 0.00 indicating that Avita Medical is being referred to more favorably in the news media.

Company Overall Sentiment
Baird Medical Investment Neutral
Avita Medical Positive

Baird Medical Investment has a net margin of 0.00% compared to Avita Medical's net margin of -62.67%.

Company Net Margins Return on Equity Return on Assets
Baird Medical InvestmentN/A N/A N/A
Avita Medical -62.67%N/A -78.92%

Baird Medical Investment has higher earnings, but lower revenue than Avita Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Baird Medical Investment$22.54M1.98N/AN/AN/A
Avita Medical$72.35M2.17-$48.59M-$1.57N/A

Summary

Avita Medical beats Baird Medical Investment on 8 of the 11 factors compared between the two stocks.

Get Baird Medical Investment News Delivered to You Automatically

Sign up to receive the latest news and ratings for BDMD and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BDMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BDMD vs. The Competition

Export
MetricBaird Medical InvestmentMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$44.26M$7.31B$6.80B$12.32B
Dividend YieldN/A1.32%2.67%9.67%
P/E RatioN/A49.8426.9224.18
Price / Sales1.9886.26483.7480.02
Price / CashN/A26.1549.7159.37
Price / BookN/A6.9410.676.25
Net IncomeN/A$162.27M$3.60B$331.66M
7 Day Performance-1.80%-2.61%-0.99%-1.32%
1 Month Performance2.83%-1.16%1.59%-1.74%
1 Year Performance-49.77%3.70%24.13%18.04%

Baird Medical Investment Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BDMD
Baird Medical Investment
N/A$1.09
+0.9%		N/A-64.4%$44.26M$22.54MN/AN/A
PDEX
Pro-Dex
3.7536 of 5 stars		$55.93
-4.0%		$70.00
+25.2%		+20.0%$178.42M$66.59M15.45140
INGN
Inogen
1.5118 of 5 stars		$6.35
+0.2%		N/A+2.2%$172.64M$348.67MN/A1,030
STEX
Biosig Technologies
3.1769 of 5 stars		$0.81
-2.1%		$8.00
+887.7%		N/A$147.44M$40KN/A50
GUTS
Fractyl Health
4.154 of 5 stars		$0.92
+14.5%		$5.12
+459.0%		-57.2%$145.16MN/AN/A102

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:BDMD) was last updated on 7/22/2026 by MarketBeat.com Staff.
From Our Partners
The options guide that actually starts at the beginning
Most options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...
Base Camp Trading | Sponsoredtc pixel
BlackRock is hoarding it. JPMorgan is hoarding it. Do you own it?
BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...
Awesomely | Sponsoredtc pixel
The Starlink of Energy
A portable energy unit - already used by the U.S. Navy for decades - is now drawing serious attention from Big...
Monument Traders Alliance | Sponsoredtc pixel
Forget SpaceX… this is the REAL #1 IPO of 2026
While SpaceX and OpenAI dominate IPO headlines, one private company is reportedly seeing the fastest revenue g...
The Oxford Club | Sponsoredtc pixel
The end may be near for these iconic stocks
Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...
Chaikin Analytics | Sponsoredtc pixel
30-Year market veteran reveals America’s #1 Stock
Market veteran Jim Woods has flagged triple-digit gains multiple times in under two months - 151% on Netflix, ...
Eagle Publishing | Sponsoredtc pixel
Not oil. Not solar. Bigger.
The International Energy Agency measured it at 140 times global electricity demand. It runs 24 hours a day, pr...
Behind the Markets | Sponsoredtc pixel
What's the Best Way to Lower RMD Taxes?
Once you turn 73, the IRS requires you to take distributions from your IRA, 401(k), and other retirement accou...
SmartAsset | Sponsoredtc pixel